RNA structures can influence many aspects of gene expression including transcription, translation, splicing, and polyadenylation. As RNA folding occurs immediately during transcription, this raises a fundamental question as to how nascent RNA structures influence RNA processing and gene expression. Here we will address aspects of this question through detailed structure-function studies of riboswitches, broadly distributed regulatory RNAs that in response to binding specific ligands can control transcription, translation and splicing. Riboswitches consist of two domains ? a highly structured aptamer that can bind a specific ligand, and a downstream expression platform that changes structure and regulates expression due to aptamer-ligand interactions. Riboswitches sense an array of metabolites, metals, ions and other small molecules to regulate essential and virulence genes in medically important pathogens such as Listeria monocytogenes, Staphylococcus aureus and Vibrio cholerae, making them of great interest as targets for novel antimicrobial therapies. They are also being developed as novel biosensors for biomedical applications. Riboswitches are powerful model systems for understanding diverse areas of RNA biology including RNA-ligand interactions, mechanisms of gene regulation, cellular RNA structures, and structure-based drug discovery. In addition, a critical feature of many riboswitches is that regulation only occurs during transcription, making them ideal model systems to study the impacts of nascent RNA structure on gene expression. Towards our long-term goal of developing a molecular understanding of how cotranscriptional RNA folding regulates and coordinates gene expression and RNA processing, we are using diverse riboswitches that regulate transcription as model systems. This proposal details a set of complementary specific aims that address fundamental questions: (1) what are the sequence determinants and transcription dynamics that promote efficient expression platform folding through cotranscriptional strand displacement, and (2) what are the mechanisms by which aptamer-ligand interactions block cotranscriptional strand displacement to enact the regulatory decision. To address these questions, we will apply a ?function-first? research strategy that uses complementary approaches including FACS-seq to rapidly functionally characterize riboswitch sequence variants in cells, cotranscriptional SHAPE-Seq (selective 2?-hydroxyl acylation analyzed by primer extension sequencing) to characterize ligand-dependent cotranscriptional folding at nucleotide resolution, RNA polymerase mutants to uncover the coupling of transcription dynamics to riboswitch folding and function, and computational data analysis approaches to study the structure-function linkage in riboswitches. Detailed knowledge of how cotranscriptional RNA folding links to nascent RNA-ligand interactions and gene regulation will contribute to a deeper understanding of gene expression processes, as well as to ongoing efforts to develop new therapeutics that target RNAs and to engineer RNA for therapeutic and biomedical applications.
Nascent RNA structures can influence gene expression and regulation, and are being linked to human diseases through mutations in RNA sequences that cause mis-folding and mis-splicing, and through prokaryotic riboswitch RNAs that use RNA-ligand interactions to regulate essential and virulence genes in pathogens such as L. monocytogenes, S. aureus and V. cholerae. This research seeks to develop a molecular understanding of how cotranscriptional RNA folding establishes nascent RNA structures that regulate and coordinate central steps of gene expression and mRNA processing through the study of transcriptional riboswitches as model systems. These studies will advance our understanding of how nascent RNA folding impacts gene expression, contribute new insights into how to target nascent RNA structures with small- molecule antibiotics and therapies, and inform the use of riboswitches as novel biosensors for biomedical applications.
